Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

SML3517

Sigma-Aldrich

Fluindione

≥98% (HPLC)

Synonym(s):

2-(4-Fluorophenyl)-1H-indene-1,3(2H)-dione, 2-(4-Fluorophenyl)indene-1,3-dione

Sign Into View Organizational & Contract Pricing

Select a Size

10 MG
€76.10
50 MG
€307.00

€76.10

Please contact Customer Service for Availability
Request a Bulk Order
All Photos(1)

Select a Size

Change View
10 MG
€76.10
50 MG
€307.00

About This Item

Empirical Formula (Hill Notation):
C15H9FO2
CAS Number:
957-56-2
Molecular Weight:
240.23
MDL number:
MFCD00239202
UNSPSC Code:
51111800
UNSPSC Code:
12352200
NACRES:
NA.77

€76.10

Please contact Customer Service for Availability
Request a Bulk Order

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C1C2=C(C(C1C3=CC=C(C=C3)F)=O)C=CC=C2

InChI

1S/C15H9FO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H

InChI key

NASXCEITKQITLD-UHFFFAOYSA-N

Biochem/physiol Actions

Fluindione is an orally active vitamin K antagonist (VKA) that exerts its in vivo anticoagulant efficacy by inhibiting the vitamin K epoxide reductase activity (VKOR IC50 = 6.6 nM) in a substrate-comeptitive manner.
Orally active vitamin K antagonist (VKA) that exerts its in vivo anticoagulant efficacy by inhibiting the vitamin K epoxide reductase (VKOR) activity.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000223277
0000223278
0000217657
0000223278
0000223277

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin
Bossavy JP, Sakariassen KS, Thalamas C, Boneu B, Cadroy Y
Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 2269-2275 (1999)
Role of ABC transporters in trans-epithelial transport of vitamin K antagonists
Bernadette Espana , Caroline Prouillac
Biopharmaceutics & Drug Disposition, 38, 20-32 (2017)
Jonaz Font et al.
Fundamental & clinical pharmacology, 32(4), 378-391 (2018-03-12)
Whether oral anticoagulants, vitamin K antagonists (VKAs), and nonvitamin K oral anticoagulant (NOACs) frequently prescribed to atrial fibrillation (AF) patients, do themselves have a pro- or anti-arrhythmic effect have never been addressed. Transmembrane action potentials were recorded in an acute
Xuejie Chen et al.
Blood, 132(18), 1974-1984 (2018-08-10)
Warfarin, acenocoumarol, phenprocoumon, and fluindione are commonly prescribed oral anticoagulants for the prevention and treatment of thromboembolic disorders. These anticoagulants function by impairing the biosynthesis of active vitamin K-dependent coagulation factors through the inhibition of vitamin K epoxide reductase (VKOR).

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service